paperKB
coga / coga-kb
Processing
Help
Sign in
2

23andMe Research Team

23andMe, Inc., Mountain View, CA, USA

TitleYearPMID
A saturated map of common genetic variants associated with human height. 2022 36224396
Genetic diversity fuels gene discovery for tobacco and alcohol use. 2022 36477530
Bi-ancestral depression GWAS in the Million Veteran Program and meta-analysis in >1.2 million individuals highlight new therapeutic directions. 2021 34045744
Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry. 2021 34728798
Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson's disease. 2020 32341526
Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. 2019 30643251
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. 2019 30478444
Genome-wide association study of alcohol use disorder identification test (AUDIT) scores in 20 328 research participants of European ancestry. 2019 29058377
Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. 2019 30718901
A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder. 2018 29325848
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. 2018 30038396
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. 2018 30150663
Multi-trait analysis of genome-wide association summary statistics using MTAG. 2018 29292387
Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders. 2018 30482948
Showing 1–14 of 14